Loading stock data…
Sight Sciences, Inc. (SGHT)
$8.10-0.25 (-2.99%)
Market ClosedLast close Sep 8
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Sight Sciences, Inc. in the Healthcare sector is trading at $8.10 with a market capitalization of $446M. Wall Street consensus targets $9.00 (5 analysts), implying a +11.1% move over the next 12 months. The stock is currently near its 52-week high of $9.24, remaining 38.5% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +11.1% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $19.70M↓ | $20.39M↑ | $19.91M↑ | $19.56M↑ | $17.51M |
| Gross Profit | $16.98M↓ | $17.79M↑ | $17.20M↑ | $16.59M↑ | $15.09M |
| Operating Income | -$12.41M↓ | -$3.67M↑ | -$7.91M↑ | -$11.67M↑ | -$13.86M |
| Net Income | -$12.98M↓ | -$4.16M↑ | -$8.17M↑ | -$11.94M↑ | -$14.15M |
Peer Comparison
JNJUNHPFE
Fundamentals
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segmen...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$446.21M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.50
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-56.26%
Volume
Today's trading volume
166,617
Recent News
Sector Update: Healthcare Stocks Gain Late Afternoon
Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index rising 3.1% a
Sector Update: Healthcare Stocks Gain Wednesday Afternoon
Healthcare stocks were higher Wednesday afternoon, with the NYSE Healthcare Index rising 2.2% and th
Sight Sciences (SGHT) Q2 2026 Earnings Call Transcript
Dry eye adoption scaled while glaucoma gained major insurance coverage.
Sight Sciences Inc (SGHT) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and Raised ...
Sight Sciences Inc (SGHT) delivers its strongest quarterly growth in three years, driven by record dry eye revenue and improved operational efficiency.
Sight Sciences Q2 Earnings Call Highlights
Sight Sciences (NASDAQ:SGHT) reported second-quarter revenue growth of 20% year over year, supported by gains in its interventional glaucoma and interventional dry eye businesses, while reducing operating expenses and cash usage. The company raised its full-year revenue outlook and lowered its adjus